Haemophilia
The Official Journal of the World Federation of Hemophilia
Edited by:
C.A. Lee and C.M. Kessler
ISI Journal Citation Reports® Ranking: 2008: 32/62 Hematology
Impact Factor: 2.394
Why read or submit to Haemophilia?
- Publishes all articles regarding the comprehensive care of haemophilia
- EarlyView - articles appear online before the paper version is published! Click here to see the articles currently available
- Online submission via - http://mc.manuscriptcentral.com/hae
- European and North American based Editorial offices
Remember all Members of the WFH qualify for a discount of over 20% on the standard subscription rate!
TopNews and Announcements
Online Content Now Available Back to Volume 1
All back issues of this journal are available online. Click here to browse contents and abstracts. For further information on how to access these articles please visit our Librarian Site.
Free Access in the Developing World
Free online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).
Articles published online ahead of print
Articles which have been fully copy-edited and peer-reviewed are published online through our OnlineEarly feature before the print edition of this journal is published.
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement.
TopHighlights
Editor's choice
Selected content from Haemophilia
Pathogenesis of haemophilic arthropathy
G Roosendaal, FP Lafeber
Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies
JW Ironside
The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization
CA Lee, C Chi, SR Pavord et al.
Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment
CPM Hayward, AK Rao and M Cattaneo
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
Scalone L, Mantovani LG, Mannucci PM, et al.
Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A
EA Chalmers, SA Brown, D Keeling et al.
Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience
M Carcao, M, St Louis J, Poon MC et al.
Cellular and genetic therapies for haemophilia
D Lillicrap, T Vandendriessche and K High
Congenital factor VII deficiency: therapy with recombinant activated factor VII - a critical appraisal
G Mariani, BA Konkle and J Ingerslev
Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia
J Astermark
